We Think That There Are Some Issues For Karolinska Development (STO:KDEV) Beyond Its Promising Earnings
May 04
Swedish (OMX) Pharma Industry Analysis
UpdatedMay 30, 2024
DataAggregated Company Financials
Companies33
- 7D6.5%
- 3M23.8%
- 1Y72.0%
- YTD9.8%
In the last week, the Pharma industry is up 8.5%, with Calliditas Therapeutics up 78%. This means that the industry has gained 72% over the past year. Earnings are forecast to grow by 53% annually.
Industry Valuation and Performance
Has the Swedish Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 30 May 2024 | kr57.3b | kr6.4b | -kr766,483,230.45 | 68.5x | -74.7x | 9x |
| Sat, 27 Apr 2024 | kr48.6b | kr6.3b | -kr978,985,196.27 | 78.7x | -49.6x | 7.7x |
| Mon, 25 Mar 2024 | kr51.9b | kr6.2b | -kr1,038,101,124.23 | 79.6x | -50x | 8.3x |
| Wed, 21 Feb 2024 | kr46.9b | kr6.1b | -kr936,395,490.37 | 84.7x | -50.1x | 7.7x |
| Fri, 19 Jan 2024 | kr69.5b | kr9.5b | -kr1,182,202,221.00 | 65.7x | -58.8x | 7.3x |
| Sun, 17 Dec 2023 | kr66.4b | kr9.4b | -kr1,184,292,161.00 | 63.3x | -56.1x | 7x |
| Tue, 14 Nov 2023 | kr57.7b | kr9.5b | -kr1,251,399,739.00 | 88.3x | -46.1x | 6.1x |
| Thu, 12 Oct 2023 | kr51.7b | kr9.2b | -kr1,181,407,160.00 | 115.9x | -43.8x | 5.6x |
| Sat, 09 Sep 2023 | kr50.8b | kr9.2b | -kr1,177,923,251.00 | 137.5x | -43.1x | 5.5x |
| Mon, 07 Aug 2023 | kr51.5b | kr8.9b | -kr1,411,083,410.00 | 86.2x | -36.5x | 5.8x |
| Wed, 05 Jul 2023 | kr48.2b | kr8.4b | -kr1,692,688,107.00 | 73.9x | -28.4x | 5.8x |
| Fri, 02 Jun 2023 | kr48.4b | kr8.4b | -kr1,594,316,588.00 | 73.7x | -30.4x | 5.8x |
| Sun, 30 Apr 2023 | kr47.1b | kr8.1b | -kr1,817,383,597.00 | 96.9x | -25.9x | 5.8x |
| Tue, 28 Mar 2023 | kr44.4b | kr8.0b | -kr1,793,565,718.00 | 85.3x | -24.8x | 5.6x |
| Thu, 23 Feb 2023 | kr44.0b | kr7.6b | -kr2,020,075,333.00 | 217.5x | -21.8x | 5.8x |
| Sat, 21 Jan 2023 | kr48.9b | kr7.3b | -kr1,938,341,442.00 | 278.2x | -25.2x | 6.7x |
| Mon, 19 Dec 2022 | kr49.4b | kr7.3b | -kr1,876,117,427.00 | 276.3x | -26.3x | 6.8x |
| Wed, 16 Nov 2022 | kr49.2b | kr6.9b | -kr1,899,260,337.00 | 53.1x | -25.9x | 7.2x |
| Fri, 14 Oct 2022 | kr48.8b | kr7.0b | -kr1,754,670,256.00 | 46.3x | -27.8x | 7x |
| Sun, 11 Sep 2022 | kr52.7b | kr7.0b | -kr1,737,204,557.00 | 55.4x | -30.3x | 7.6x |
| Tue, 09 Aug 2022 | kr53.6b | kr6.9b | -kr1,535,099,047.00 | 41.3x | -34.9x | 7.8x |
| Thu, 07 Jul 2022 | kr53.6b | kr5.9b | -kr1,509,116,648.00 | 42.5x | -35.5x | 9x |
| Sat, 04 Jun 2022 | kr54.2b | kr5.9b | -kr1,505,666,101.00 | 44.6x | -36x | 9.1x |
| Mon, 02 May 2022 | kr54.7b | kr5.5b | -kr1,351,308,728.00 | 38x | -40.5x | 9.9x |
| Wed, 30 Mar 2022 | kr54.0b | kr5.4b | -kr1,280,292,342.00 | 40.7x | -42.2x | 10x |
| Fri, 25 Feb 2022 | kr46.5b | kr5.4b | -kr1,090,445,538.00 | 76.5x | -42.7x | 8.7x |
| Sun, 23 Jan 2022 | kr49.1b | kr5.5b | -kr1,083,939,448.00 | 112.1x | -45.3x | 9x |
| Tue, 21 Dec 2021 | kr54.9b | kr5.5b | -kr1,100,435,867.00 | 114.1x | -49.9x | 10.1x |
| Thu, 18 Nov 2021 | kr59.2b | kr5.3b | -kr1,373,136,928.00 | 88x | -43.1x | 11.3x |
| Sat, 16 Oct 2021 | kr52.8b | kr4.8b | -kr1,581,702,061.00 | 140.1x | -33.4x | 11x |
| Mon, 13 Sep 2021 | kr57.3b | kr4.8b | -kr1,560,489,765.26 | 149.5x | -36.7x | 12x |
| Wed, 11 Aug 2021 | kr55.3b | kr4.8b | -kr1,412,039,942.26 | 161.6x | -39.2x | 11.6x |
| Sun, 06 Jun 2021 | kr53.2b | kr4.6b | -kr1,469,283,209.50 | 173.3x | -36.2x | 11.7x |
Price to Earnings Ratio
-36.2x
Current Industry PE
- Investors are optimistic on the Swedish Pharmaceuticals industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 8.1x is lower than the industry's current PS ratio of 9.1x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
- Revenues for these companies have grown 12% per year.
- This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Trends
Which industries have driven the changes within the Swedish Healthcare industry?
| SE Market | -2.24% | |
| Healthcare | -0.33% | |
| Pharma | 6.50% | |
| Pharma | 6.50% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CALTX Calliditas Therapeutics | kr203.20 | 78.2% +kr4.8b | 121.1% | PS9x | |
| SECARE Swedencare | kr59.00 | 1.2% +kr111.1m | 32.4% | PE131x | |
| KLAR Klaria Pharma Holding AB (publ.) | kr0.93 | 97.4% +kr59.4m | 93.3% | PB4.1x | |
| IBT B Infant Bacterial Therapeutics | kr100.00 | 4.2% +kr53.9m | 124.7% | PS19523.8x | |
| CLBIO Corline Biomedical | kr11.20 | 9.8% +kr21.5m | -26.8% | PS7.8x |